Statistics

Total Visits

Views
Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: a Spanish Cooperative Group for the Treatment of Digestive Tumors study37

Select a period of time:

Number of views in the range

Views
Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: a Spanish Cooperative Group for the Treatment of Digestive Tumors study20

Views

Views
January 20251
February 20252
March 202514
April 20253
May 20250
June 20250
July 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore14
United States4
Spain1
United Kingdom1
 

Top cities views

Views
Council Bluffs1
Dallas1
Lombard1